Landscape Capital Management’s Envoy Medical COCH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-30,020
Closed -$301K 679
2022
Q4
$301K Hold
30,020
0.04% 393
2022
Q3
$295K Buy
30,020
+17,439
+139% +$171K 0.04% 464
2022
Q2
$123K Hold
12,581
0.02% 809
2022
Q1
$123K Hold
12,581
0.02% 810
2021
Q4
$123K Hold
12,581
0.02% 728
2021
Q3
$122K Buy
+12,581
New +$122K 0.02% 684

Other funds holding COCH

Landscape Capital Management's COCH Position: Q1 2023 in Review

Landscape Capital Management sold out of Envoy Medical (COCH) in Q1 2023, closing a stake of 30,020 shares — an estimated $301K sold.

Landscape Capital Management first reported a position in COCH in Q3 2021 and held it in 6 quarters. The position peaked at $301K in Q4 2022. 24 funds tracked by Wall St. Rank hold COCH as of Q1 2023.

  • Landscape Capital Management reported no remaining Envoy Medical position as of Q1 2023 after selling out during the quarter.
  • Landscape Capital Management sold 30,020 Envoy Medical shares in Q1 2023, an estimated $301K.
  • Landscape Capital Management first reported a position in Envoy Medical in Q3 2021 and held it in 6 quarters.
  • Landscape Capital Management's Envoy Medical position peaked at $301K in Q4 2022.
  • 24 funds tracked by Wall St. Rank held Envoy Medical as of Q1 2023.

Based on Landscape Capital Management's 13F filing for Q1 2023, filed 10 May 2023.